카프노그래피 시장 : 예측(2025-2030년)

The Capnography Market is expected to grow from USD 1.891 billion in 2025 to USD 2.977 billion in 2030, at a CAGR of 9.50%.

Capnography Market Trends

Capnography involves measuring the concentration or partial pressure of carbon dioxide in patients' exhaled breath. It serves as essential monitoring equipment in settings such as critical care, recovery rooms, wards, and ambulances. As a non-invasive method, it enables rapid identification of respiratory issues, including ventilator failure, tracheal tube malposition, and defective breathing circuits. The technology presents exhaled CO2 as a waveform, illustrating CO2 levels throughout the respiratory cycle.

Technological advancements are a primary driver of the capnography market, enabling earlier and more efficient disease detection. However, market growth faces limitations from alternative technologies like pulse oximetry, which also monitors respiration, and the unreliability of capnography for measuring respiratory rates in non-intubated patients.

The escalating prevalence of respiratory diseases-including infections, asthma, lung cancer, and chronic obstructive pulmonary disease (COPD)-in both developed and developing countries continues to propel market expansion. These chronic conditions affect airways and lung structures over extended periods, making respiratory symptoms a leading reason for primary care consultations. Smoking remains a key contributor to this rise, with COPD linked to tobacco use impacting significant populations worldwide.

Ambulatory surgical centers (ASCs) have seen substantial expansion in service types and volumes, encompassing diverse specialties like cardiology. Even fields traditionally hospital-based, such as spine and joint replacements, are increasingly shifting to ASCs. This transition underscores the growing role of outpatient settings in healthcare delivery.

Market growth is further supported by ongoing technological innovations, the rising incidence of respiratory diseases, and government initiatives promoting advanced monitoring. The increasing adoption of capnography for patient monitoring stems from its superior reliability and efficiency in managing respiratory conditions, enhancing overall medical outcomes.

Capnography Market Segmentation Analysis

The expanding applications of capnography in cardiac care are poised to drive market growth during the forecast period. This surge is fueled by the increasing prevalence of cardiovascular diseases (CVDs) and a growing volume of global surgeries. Heart conditions, including CVD, congenital heart disease (CHD), and stroke, rank among the top causes of mortality worldwide. Projections indicate that by 2030, CVDs could account for approximately 23.6 million deaths globally. Notably, around 80% of CVD-related deaths occur in low- and middle-income regions, such as Africa, Latin America, and Asia-Pacific.

Key risk factors exacerbating CVD incidence include excessive alcohol and tobacco consumption, poor dietary habits, and sedentary lifestyles. These elements contribute to rising heart disease rates, which in turn heighten the need for capnography devices in cardiology. The demand is amplified by the potential for rapid fatalities from these conditions, necessitating robust monitoring tools.

A notable trend is the shift toward point-of-care cardiac services in ASCs, which further boosts capnography adoption. As patient care increasingly moves to outpatient environments, ASCs emerge as cost-effective, high-quality alternatives to traditional hospitals. This evolution supports broader procedural scopes, including cardiac interventions, where capnography ensures real-time respiratory oversight during surgeries and recovery.

Overall, the capnography market is positioned for sustained growth, driven by its critical role in addressing respiratory and cardiac challenges. While technological alternatives pose competition, the device's non-invasive nature and waveform-based insights provide distinct advantages in high-stakes clinical scenarios. Industry stakeholders should monitor advancements in integration with other monitoring systems and regulatory support to capitalize on emerging opportunities in ambulatory and critical care settings. The focus on reliability for intubated patients, combined with efforts to improve accuracy for non-intubated cases, will be key to overcoming restraints and expanding market penetration.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2022 to 2024 & forecast data from 2025 to 2030
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Capnography Market Segmentation:

By Product Type

• Sidestream Capnographs
• Mainstream Capnographs
• Microstream Capnographs

By Application

• Procedural Sedation
• Pain Management
• Emergency Medicine
• Anesthesia Monitoring
• Critical Care
• Others

By End-User

• Hospitals
• Ambulatory Surgical Centers (ASCs)
• Emergency Medical Services (EMS)
• Homecare Settings
• Diagnostic Laboratories

By Geography

• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Others
• Asia Pacific
• China
• Japan
• India
• South Korea
• Taiwan
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. CAPNOGRAPHY MARKET BY PRODUCT TYPE

• 5.1. Introduction
• 5.2. Sidestream Capnographs
• 5.3. Mainstream Capnographs
• 5.4. Microstream Capnographs

6. CAPNOGRAPHY MARKET BY APPLICATION

• 6.1. Introduction
• 6.2. Procedural Sedation
• 6.3. Pain Management
• 6.4. Emergency Medicine
• 6.5. Anesthesia Monitoring
• 6.6. Critical Care
• 6.7. Others

7. CAPNOGRAPHY MARKET BY END-USER

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Ambulatory Surgical Centers (ASCs)
• 7.4. Emergency Medical Services (EMS)
• 7.5. Homecare Settings
• 7.6. Diagnostic Laboratories

8. CAPNOGRAPHY MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. By Product Type
  • 8.2.2. By Application
  • 8.2.3. By End-User
  • 8.2.4. By Country
    • 8.2.4.1. USA
    • 8.2.4.2. Canada
    • 8.2.4.3. Mexico
• 8.3. South America
  • 8.3.1. By Product Type
  • 8.3.2. By Application
  • 8.3.3. By End-User
  • 8.3.4. By Country
    • 8.3.4.1. Brazil
    • 8.3.4.2. Argentina
    • 8.3.4.3. Others
• 8.4. Europe
  • 8.4.1. By Product Type
  • 8.4.2. By Application
  • 8.4.3. By End-User
  • 8.4.4. By Country
    • 8.4.4.1. United Kingdom
    • 8.4.4.2. Germany
    • 8.4.4.3. France
    • 8.4.4.4. Spain
    • 8.4.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. By Product Type
  • 8.5.2. By Application
  • 8.5.3. By End-User
  • 8.5.4. By Country
    • 8.5.4.1. Saudi Arabia
    • 8.5.4.2. UAE
    • 8.5.4.3. Others
• 8.6. Asia Pacific
  • 8.6.1. By Product Type
  • 8.6.2. By Application
  • 8.6.3. By End-User
  • 8.6.4. By Country
    • 8.6.4.1. China
    • 8.6.4.2. Japan
    • 8.6.4.3. India
    • 8.6.4.4. South Korea
    • 8.6.4.5. Taiwan
    • 8.6.4.6. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Medtronic plc
• 10.2. Masimo Corporation
• 10.3. Dragerwerk AG & Co. KGaA
• 10.4. Koninklijke Philips N.V.
• 10.5. ICU Medical
• 10.6. Nonin Medical Inc.
• 10.7. Nihon Kohden Corporation
• 10.8. Becton, Dickinson and Company (BD)
• 10.9. Zoll Medical Corporation

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key benefits for the stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations